P&G and AS Watson are looking for startup partnerships to build new, personalized, effortless, and cost-effective ways to enhance the overall shopper experience Online + Offline through the Guided Selling Challenge and the Social Commerce Challenge.
BHP Xplor is a 6-month, accelerator program targeting innovative, early-stage mineral exploration companies to find the critical resources necessary to drive the energy transition.
Nexa is seeking innovative solutions that allow consolidating data on the pandemic, generating information on prevention and care actions, allocating resources more efficiently and using geolocation to support faster and better decision-making in fighting the pandemic.
Rio Tinto seeks sensing technology solutions for environmental monitoring and waste streams characterisation.
A leading Japanese manufacturer of functional materials -- including in the fields of electronics, automotive, housing, infrastructure, environmental and medical -- is seeking startups to collaborate with for the design and development of new products using ambient curable adhesive sheet.
We are looking to partner with experts to find, develop, and validate selective solutions that can target and efficiently remove targeted constituents from mine-influenced water (MIW) to enhance water recovery, reduce residual wastes, and the recovery of resources to generate new revenue streams and offset closure costs.
Braskem is a $15B global plastic manufacturer in Brazil. They are looking to manufacture Plastic/composite ties that will outlast wood, ideally using recycled material. They currently have this capability but are looking for product advantage/benefits around: rail/wheel interaction; ballast’s maintenance consumption; Life Cycle cost of the tie; Environment requisitions; and pavement’s levels design.
"A call to automate the automation," Thomas Fuhlbrigge, Global Program Manager, Next Generation Robotics, ABB
Looking for 8-10 startups to present their tech on April 12 at the 2022 MIT Health Science Technologies Conference: The Future of Cell & Gene Therapies.